Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; General Licensing Provisions; Section 351(k) Biosimilar Applications

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "General Licensing Provisions; Section 351(k) Biosimilar Applications" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.